{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:12:39Z","timestamp":1778778759089,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,27]]},"DOI":"10.7759\/cureus.59153","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T16:29:48Z","timestamp":1714235388000},"source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of Vitamin D and Alpha-Lipoic Acid in COVID-19 Infection: A Literature Review"],"prefix":"10.7759","author":[{"given":"Martin","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Aulick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO COVID-19 dashboard. Accessed. January 5, 2024: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"ref2","unstructured":"Know your treatment options for COVID-19. (2024). Accessed. March 1, 2024: https:\/\/www.fda.gov\/consumers\/consumer-updates\/know-your-treatment-options-covid-19."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5849(97)00371-7","article-title":"Alpha-lipoic acid in liver metabolism and disease","volume":"24","author":"Bustamante J","year":"1998","unstructured":"Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH. Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med. 1998, 24:1023-39. 10.1016\/s0891-5849(97)00371-7","journal-title":"Free Radic Biol Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/nu7064240","article-title":"Modulation of the immune response to respiratory viruses by vitamin D","volume":"7","author":"Greiller CL","year":"2015","unstructured":"Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015, 7:4240-70. 10.3390\/nu7064240","journal-title":"Nutrients"},{"key":"ref5","article-title":"Vitamin D and the immune system","volume":"19","author":"Azrielant S","year":"2017","unstructured":"Azrielant S, Shoenfeld Y. Vitamin D and the immune system. Isr Med Assoc J. 2017, 19:510-1.","journal-title":"Isr Med Assoc J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.566609","article-title":"A randomized, single-blind, group sequential, active-controlled study to evaluate the clinical efficacy and safety of \u03b1-lipoic acid for critically ill patients with coronavirus disease 2019 (COVID-19)","volume":"8","author":"Zhong M","year":"2021","unstructured":"Zhong M, Sun A, Xiao T, et al.. A randomized, single-blind, group sequential, active-controlled study to evaluate the clinical efficacy and safety of \u03b1-lipoic acid for critically ill patients with coronavirus disease 2019 (COVID-19). Front Med (Lausanne). 2021, 8:566609. 10.3389\/fmed.2021.566609","journal-title":"Front Med (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2022.04.003","article-title":"Efficacy and safety of vitamin D supplementation to prevent COVID-19 in frontline healthcare workers. A randomized clinical trial","volume":"53","author":"Villasis-Keever MA","year":"2022","unstructured":"Villasis-Keever MA, L\u00f3pez-Alarc\u00f3n MG, Miranda-Novales G, et al.. Efficacy and safety of vitamin D supplementation to prevent COVID-19 in frontline healthcare workers. A randomized clinical trial. Arch Med Res. 2022, 53:423-30. 10.1016\/j.arcmed.2022.04.003","journal-title":"Arch Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072170","article-title":"Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate COVID-19: a randomized clinical trial","volume":"13","author":"Sabico S","year":"2021","unstructured":"Sabico S, Enani MA, Sheshah E, et al.. Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate COVID-19: a randomized clinical trial. Nutrients. 2021, 13:10.3390\/nu13072170","journal-title":"Nutrients"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101358","article-title":"Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate-to-severe COVID-19 patients: a randomized clinical trial","volume":"58","author":"Sarhan N","year":"2022","unstructured":"Sarhan N, Abou Warda AE, Sarhan RM, et al.. Evidence for the efficacy of a high dose of vitamin D on the hyperinflammation state in moderate-to-severe COVID-19 patients: a randomized clinical trial. Medicina (Kaunas). 2022, 58:10.3390\/medicina58101358","journal-title":"Medicina (Kaunas)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/nu15051234","article-title":"Vitamin D supplementation and clinical outcomes in severe COVID-19 patients-randomized controlled trial","volume":"15","author":"Domazet Bugarin J","year":"2023","unstructured":"Domazet Bugarin J, Dosenovic S, Ilic D, et al.. Vitamin D supplementation and clinical outcomes in severe COVID-19 patients-randomized controlled trial. Nutrients. 2023, 15:10.3390\/nu15051234","journal-title":"Nutrients"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071245","article-title":"Prevention of COVID-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial","volume":"378","author":"Brunvoll SH","year":"2022","unstructured":"Brunvoll SH, Nygaard AB, Ellingjord-Dale M, et al.. Prevention of COVID-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial. BMJ. 2022, 378:e071245. 10.1136\/bmj-2022-071245","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111899","article-title":"REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients","volume":"107","author":"Bishop CW","year":"2023","unstructured":"Bishop CW, Ashfaq A, Melnick JZ, et al.. REsCue trial: Randomized controlled clinical trial with extended-release calcifediol in symptomatic COVID-19 outpatients. Nutrition. 2023, 107:111899. 10.1016\/j.nut.2022.111899","journal-title":"Nutrition"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112965","article-title":"Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D","volume":"150","author":"Torres M","year":"2022","unstructured":"Torres M, Casado G, Vig\u00f3n L, et al.. Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D. Biomed Pharmacother. 2022, 150:112965. 10.1016\/j.biopha.2022.112965","journal-title":"Biomed Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-139065","article-title":"Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)","volume":"98","author":"Rastogi A","year":"2022","unstructured":"Rastogi A, Bhansali A, Khare N, et al.. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J. 2022, 98:87-90. 10.1136\/postgradmedj-2020-139065","journal-title":"Postgrad Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116175","article-title":"A randomized pilot study using calcitriol in hospitalized COVID-19 patients","volume":"154","author":"Elamir YM","year":"2022","unstructured":"Elamir YM, Amir H, Lim S, et al.. A randomized pilot study using calcitriol in hospitalized COVID-19 patients. Bone. 2022, 154:116175. 10.1016\/j.bone.2021.116175","journal-title":"Bone"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.09.016","article-title":"Treatment with 25-hydroxyvitamin D(3) (calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in hospitalized patients with COVID-19: a pilot multicenter, randomized, placebo-controlled, Dou","volume":"27","author":"Maghbooli Z","year":"2021","unstructured":"Maghbooli Z, Sahraian MA, Jamalimoghadamsiahkali S, et al.. Treatment with 25-hydroxyvitamin D(3) (calcifediol) is associated with a reduction in the blood neutrophil-to-lymphocyte ratio marker of disease severity in hospitalized patients with COVID-19: a pilot multicenter, randomized, placebo-controlled, Dou. Endocr Pract. 2021, 27:1242-51. 10.1016\/j.eprac.2021.09.016","journal-title":"Endocr Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-017-9424-1","article-title":"The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention","volume":"18","author":"Holick MF","year":"2017","unstructured":"Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017, 18:153-65. 10.1007\/s11154-017-9424-1","journal-title":"Rev Endocr Metab Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)78933-9","article-title":"Redefining vitamin D insufficiency","volume":"351","author":"Malabanan A","year":"1998","unstructured":"Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet Lond Engl. 1998, 351:805-6. 10.1016\/s0140-6736(05)78933-9","journal-title":"Lancet Lond Engl"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick MF","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011, 96:1911-30. 10.1210\/jc.2011-0385","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12631","article-title":"Recommendations abstracted from the American Geriatrics Society consensus statement on vitamin D for prevention of falls and their consequences","volume":"62","year":"2014","unstructured":"Recommendations abstracted from the American Geriatrics Society consensus statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc. 2014, 62.147-52. 10.1111\/jgs.12631","journal-title":"J Am Geriatr Soc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-008-9085-1","article-title":"Pediatric vitamin D and calcium nutrition in developing countries","volume":"9","author":"Fischer PR","year":"2008","unstructured":"Fischer PR, Thacher TD, Pettifor JM. Pediatric vitamin D and calcium nutrition in developing countries. Rev Endocr Metab Disord. 2008, 9:181-92. 10.1007\/s11154-008-9085-1","journal-title":"Rev Endocr Metab Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.05.011","article-title":"Vitamin D for health: a global perspective","volume":"88","author":"Hossein-nezhad A","year":"2013","unstructured":"Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013, 88:720-55. 10.1016\/j.mayocp.2013.05.011","journal-title":"Mayo Clin Proc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04320.x","article-title":"Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study","volume":"77","author":"Daly RM","year":"2012","unstructured":"Daly RM, Gagnon C, Lu ZX, et al.. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf). 2012, 77:26-35. 10.1111\/j.1365-2265.2011.04320.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1163737","article-title":"Prevalence of vitamin D deficiency and associated risk of all-cause and cause-specific mortality among middle-aged and older adults in the United States","volume":"10","author":"Wang TY","year":"2023","unstructured":"Wang TY, Wang HW, Jiang MY. Prevalence of vitamin D deficiency and associated risk of all-cause and cause-specific mortality among middle-aged and older adults in the United States. Front Nutr. 2023, 10:1163737. 10.3389\/fnut.2023.1163737","journal-title":"Front Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/0009922806289311","article-title":"Vitamin D deficiency in a healthy group of mothers and newborn infants","volume":"46","author":"Lee JM","year":"2007","unstructured":"Lee JM, Smith JR, Philipp BL, Chen TC, Mathieu J, Holick MF. Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin Pediatr (Phila). 2007, 46:42-4. 10.1177\/0009922806289311","journal-title":"Clin Pediatr (Phila)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/86.3.714","article-title":"An association of serum vitamin D concentrations < 40 nmol\/L with acute respiratory tract infection in young Finnish men","volume":"86","author":"Laaksi I","year":"2007","unstructured":"Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajam\u00e4ki H, Ylikomi T. An association of serum vitamin D concentrations &lt; 40 nmol\/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007, 86:714-7. 10.1093\/ajcn\/86.3.714","journal-title":"Am J Clin Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1086\/654881","article-title":"Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men","volume":"202","author":"Laaksi I","year":"2010","unstructured":"Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajam\u00e4ki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis. 2010, 202:809-14. 10.1086\/654881","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065835","article-title":"Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Bergman P","year":"2013","unstructured":"Bergman P, Lindh AU, Bj\u00f6rkhem-Bergman L, Lindh JD. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2013, 8:e65835. 10.1371\/journal.pone.0065835","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.560","article-title":"Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey","volume":"169","author":"Ginde AA","year":"2009","unstructured":"Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009, 169:384-90. 10.1001\/archinternmed.2008.560","journal-title":"Arch Intern Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus","volume":"201","author":"Wark PA","year":"2005","unstructured":"Wark PA, Johnston SL, Bucchieri F, et al.. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005, 201:937-47. 10.1084\/jem.20041901","journal-title":"J Exp Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.94.07081439","article-title":"The expression of intercellular adhesion molecule-1 and the beta 1-integrins in asthma","volume":"7","author":"Manolitsas ND","year":"1994","unstructured":"Manolitsas ND, Trigg CJ, McAulay AE, Wang JH, Jordan SE, D'Ardenne AJ, Davies RJ. The expression of intercellular adhesion molecule-1 and the beta 1-integrins in asthma. Eur Respir J. 1994, 7:1439-44. 10.1183\/09031936.94.07081439","journal-title":"Eur Respir J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6583","article-title":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data","volume":"356","author":"Martineau AR","year":"2017","unstructured":"Martineau AR, Jolliffe DA, Hooper RL, et al.. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017, 356:i6583. 10.1136\/bmj.i6583","journal-title":"BMJ"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000001331","article-title":"How many SARS-CoV-2-infected people require hospitalization? Using random sample testing to better inform preparedness efforts","volume":"27","author":"Menachemi N","year":"2021","unstructured":"Menachemi N, Dixon BE, Wools-Kaloustian KK, Yiannoutsos CT, Halverson PK. How many SARS-CoV-2-infected people require hospitalization? Using random sample testing to better inform preparedness efforts. J Public Health Manag Pract. 2021, 27:246-50. 10.1097\/PHH.0000000000001331","journal-title":"J Public Health Manag Pract"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang X","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020, 8:475-81. 10.1016\/S2213-2600(20)30079-5","journal-title":"Lancet Respir Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30268-0","article-title":"Vitamin D for COVID-19: a case to answer?","volume":"8","author":"Martineau AR","year":"2020","unstructured":"Martineau AR, Forouhi NG. Vitamin D for COVID-19: a case to answer?. Lancet Diabetes Endocrinol. 2020, 8:735-6. 10.1016\/S2213-8587(20)30268-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.32394\/rpzh.2022.0191","article-title":"Vitamin D in SARS-CoV-2 infection","volume":"73","author":"Decyk A","year":"2022","unstructured":"Decyk A, Kobyli\u0144ska M, Antosik K, Kurowska K. Vitamin D in SARS-CoV-2 infection. Rocz Panstw Zakl Hig. 2022, 73:5-12. 10.32394\/rpzh.2022.0191","journal-title":"Rocz Panstw Zakl Hig"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-022-00732-z","article-title":"Vitamin D Regulation of Immune Function","volume":"20","author":"Bikle DD","year":"2022","unstructured":"Bikle DD. Vitamin D Regulation of Immune Function. Curr Osteoporos Rep. 2022, 20:186-93. 10.1007\/s11914-022-00732-z","journal-title":"Curr Osteoporos Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-020-01570-8","article-title":"The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality","volume":"32","author":"Ilie PC","year":"2020","unstructured":"Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020, 32:1195-8. 10.1007\/s40520-020-01570-8","journal-title":"Aging Clin Exp Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030925","article-title":"Evaluation of in vitro and in vivo antiviral activities of Vitamin D for SARS-CoV-2 and variants","volume":"15","author":"Mok CK","year":"2023","unstructured":"Mok CK, Ng YL, Ahidjo BA, et al.. Evaluation of in vitro and in vivo antiviral activities of Vitamin D for SARS-CoV-2 and variants. Pharmaceutics. 2023, 15:10.3390\/pharmaceutics15030925","journal-title":"Pharmaceutics"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239799","article-title":"Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng\/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection","volume":"15","author":"Maghbooli Z","year":"2020","unstructured":"Maghbooli Z, Sahraian MA, Ebrahimi M, et al.. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng\/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One. 2020, 15:e0239799. 10.1371\/journal.pone.0239799","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105751","article-title":"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study","volume":"203","author":"Entrenas Castillo M","year":"2020","unstructured":"Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcal\u00e1 D\u00edaz JF, L\u00f3pez Miranda J, Bouillon R, Quesada Gomez JM. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020, 203:105751. 10.1016\/j.jsbmb.2020.105751","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15495","article-title":"Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study","volume":"287","author":"Merzon E","year":"2020","unstructured":"Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, Frenkel-Morgenstern M. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. 2020, 287:3693-702. 10.1111\/febs.15495","journal-title":"FEBS J"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239252","article-title":"SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels","volume":"15","author":"Kaufman HW","year":"2020","unstructured":"Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One. 2020, 15:e0239252. 10.1371\/journal.pone.0239252","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol","volume":"77","author":"Heaney RP","year":"2003","unstructured":"Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003, 77:204-10. 10.1093\/ajcn\/77.1.204","journal-title":"Am J Clin Nutr"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111265","article-title":"The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers","volume":"9","author":"Ekwaru JP","year":"2014","unstructured":"Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014, 9:e111265. 10.1371\/journal.pone.0111265","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(95)00017-r","article-title":"alpha-Lipoic acid as a biological antioxidant","volume":"19","author":"Packer L","year":"1995","unstructured":"Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med. 1995, 19:227-50. 10.1016\/0891-5849(95)00017-r","journal-title":"Free Radic Biol Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-3623(96)00474-0","article-title":"The pharmacology of the antioxidant lipoic acid","volume":"29","author":"Biewenga GP","year":"1997","unstructured":"Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 1997, 29:315-31. 10.1016\/s0306-3623(96)00474-0","journal-title":"Gen Pharmacol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1080\/10715769900300721","article-title":"Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (Aladin II). Alpha lipoic acid in diabetic neuropathy","volume":"31","author":"Reljanovic M","year":"1999","unstructured":"Reljanovic M, Reichel G, Rett K, et al.. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (Aladin II). Alpha lipoic acid in diabetic neuropathy. Free Radic Res. 1999, 31:171-9. 10.1080\/10715769900300721","journal-title":"Free Radic Res"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2006.06.004","article-title":"Safety evaluation of alpha-lipoic acid (ALA)","volume":"46","author":"Cremer DR","year":"2006","unstructured":"Cremer DR, Rabeler R, Roberts A, Lynch B. Safety evaluation of alpha-lipoic acid (ALA). Regul Toxicol Pharmacol. 2006, 46:29-41. 10.1016\/j.yrtph.2006.06.004","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4103\/cp.cp_16_20","article-title":"Cardioprotective effect of alpha-lipoic acid and its mechanisms","volume":"5","author":"Hu QF","year":"2020","unstructured":"Hu QF, Sun AJ. Cardioprotective effect of alpha-lipoic acid and its mechanisms. Cardiol Plus. 2020, 5:109-17. 10.4103\/cp.cp_16_20","journal-title":"Cardiol Plus"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13314","article-title":"\u03b1-lipoic acid reduces postreperfusion syndrome in human liver transplantation - a pilot study","volume":"31","author":"Casciato P","year":"2018","unstructured":"Casciato P, Ambrosi N, Caro F, et al.. \u03b1-lipoic acid reduces postreperfusion syndrome in human liver transplantation - a pilot study. Transpl Int. 2018, 31:1357-68. 10.1111\/tri.13314","journal-title":"Transpl Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/246874-effectiveness-of-vitamin-d-and-alpha-lipoic-acid-in-covid-19-infection-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T16:29:54Z","timestamp":1714235394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/246874-effectiveness-of-vitamin-d-and-alpha-lipoic-acid-in-covid-19-infection-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.59153","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,27]]}}}